Workshop Presentations
Ductal Carcinoma in Situ: Strategies for Integrating Tumor Biology and Populations Sciences Workshop
Rachel Ballard-Barbash, MD, MPH
Overview of the current definition of Ductal Carcinoma in Situ
Donald L. Weaver, MD University of Vermont
Epidemiology of DCIS
Karla Kerlikowske, MD; University of California at San Francisco
Overview of the Basic Biology: Precursors Through Invasive Disease and Future Directions
Thea Tlsty, PhD, University of California at San Francisco
Problems in the Diagnosis of Ductal Carcinoma in Situ
Stuart J. Schnitt, MD; Beth Israel Deaconess Medical Center & Harvard Medical School
Overview of Treatment
Monica Morrow, MD; Temple University School of Medicine
Predictors of DCIS Recurrence and Risk of Invasive Cancer: Overview of the Field and Current Challenges
Lawrence J. Solin, MD, FACR; University of Pennsylvania
Statistical Issues in Investigating Prognostic and Predictive Markers for DCIS
James J. Dignam, PhD; The University of Chicago
Predicting Local Invasive Recurrence After Conservative Treatment
Melvin Silverstein, MD; The USC/Norris Comprehensive Cancer Center
Impact of Pathology Practice on Outcome in Published Studies of DCIS.
Recommendations for a Uniform Pathology Protocol
Michael D. Lagios; The Breast Cancer Consultation Service
Overview of State-of-the-Field and Challenges in Collaboration
Laura Esserman, MD; University of San Francisco
Approaches to Evaluation and Validation of Therapeutically Relevant Biomarkers
Annette Molinaro, PhD; Yale University School of Medicine
A Systems Approach to Predicting Drug Response
Joe W. Gray, PhD; Lawrence Berkeley National Laboratory
New Markers and Drug Therapies Being Examined in DCIS Trials
Saraswati Sukumar, PhD; Johns Hopkins University School of Medicine
Imaging: State of the Science and New Directions
Laura Liberman, MD; Memorial Sloan-Kettering Cancer Center
Meeting the Research Challenges: Update on Current Population-Level DCIS Research
Laurel Habel, PhD; Kaiser Permanente
DCIS and the Development of Diversity During Breast Cancer Evolution
Craig Allred, MD; Washington University School of Medicine
Panel: Strategies for addressing common concerns in collaborative research and how to maximize existing resources?
Graham Colditz MD, DrPH; Washington University School of Medicine
Larissa Nekhlyudov, MD, MPH, Harvard Medical School
James Dignam, Ph.D., University of Chicago
[Return to top]
|
